TY - JOUR T1 - A double blind, parallel, placebo controlled, dose ranging study on efficacy and safety of oral clodronate in cancer induced osteolysis measured by biochemical markers of bone resorption JO - Journal of Clinical Oncology PY - 2004/07/15 AU - Brown JE AU - McCloskey E AU - Dewar JA AU - Body J-J AU - Cameron DA AU - Purohit OP-K AU - Harnett A AU - Tahtela R AU - Kurkilahti M AU - Coleman RE ED - DO - DOI: 10.1200/jco.2004.22.14_suppl.8056 PB - American Society of Clinical Oncology (ASCO) VL - 22 IS - 14_suppl SP - 8056 EP - 8056 Y2 - 2025/05/17 ER -